Z-WEHD-FMK: Irreversible Caspase-5 Inhibitor for Inflammation and Apoptosis Research

Executive Summary: Z-WEHD-FMK (CAS 210345-00-9) is a peptide-based, irreversible, cell-permeable inhibitor targeting inflammatory caspases, including caspase-1, -4, and -5, with high specificity (APExBIO). It prevents caspase-mediated proteolytic cleavage, disrupting key cellular processes in inflammation and apoptosis (Padia et al., 2025). In Chlamydia-infected cell models, Z-WEHD-FMK blocks golgin-84 cleavage, suppresses bacterial proliferation, and alters lipid trafficking. The inhibitor is insoluble in water but readily dissolves in DMSO or ethanol, offering flexible experimental design. Long-term storage of prepared solutions is not recommended; the lyophilized product should be kept at -20°C to maintain stability.

Biological Rationale

Caspases are cysteine-aspartic proteases central to programmed cell death and inflammatory signaling. Inflammation-related caspases, especially caspase-1, -4, and -5 in humans, cleave and activate gasdermin D, leading to pyroptosis, an inflammatory form of cell death (Padia et al., 2025). Non-canonical inflammasome activation involves direct recognition of cytosolic LPS by caspase-4/5, triggering pyroptosis independent of ASC. Dysregulated caspase signaling is implicated in infectious diseases, cancer, and immune pathologies. In infectious disease models, such as Chlamydia trachomatis infection, inflammatory caspase activity contributes to host-pathogen dynamics via substrate cleavage (e.g., golgin-84), impacting intracellular bacterial survival and replication. The ability to pharmacologically inhibit these caspases is essential for dissecting their roles in both cell death and complex signaling pathways (see scenario-driven guidance).

Mechanism of Action of Z-WEHD-FMK

Z-WEHD-FMK (Z-Trp-Glu(OMe)-His-Asp(OMe)-FMK) is a synthetic peptide inhibitor featuring a fluoromethyl ketone (FMK) reactive group. The FMK moiety covalently and irreversibly modifies the active-site cysteine of target caspases. This results in permanent inactivation of caspase-1, -4, and -5 protease activity. The compound is cell-permeable, enabling intracellular inhibition of caspase-mediated cleavage events. In Chlamydia models, Z-WEHD-FMK blocks the cleavage of golgin-84, a critical step in pathogen-induced Golgi fragmentation and subsequent bacterial proliferation (see mechanistic update). Because Z-WEHD-FMK acts irreversibly, its effect persists for the duration of the experiment, but does not distinguish between active and inactive caspase pools. The compound's selectivity profile minimizes off-target effects compared to pan-caspase inhibitors, supporting advanced studies of non-canonical pyroptosis and inflammation mechanisms (for advanced strategies).

Evidence & Benchmarks

• Z-WEHD-FMK (80 μM, 9 h) blocks golgin-84 cleavage in Chlamydia trachomatis-infected HeLa cells, reducing bacterial counts by ~2 logs (Padia et al., 2025).
• The compound is insoluble in water but soluble in DMSO (≥46.33 mg/mL) and ethanol (≥26.32 mg/mL with sonication), supporting flexible assay design (APExBIO).
• Z-WEHD-FMK is irreversible, requiring no repeated dosing during short-term cell-based experiments (benchmark guide).
• In non-small cell lung carcinoma models, suppression of caspase-1 (the primary Z-WEHD-FMK target) prevents pyroptotic cell death, validating the inhibitor's mechanistic basis (Padia et al., 2025).
• Z-WEHD-FMK provides superior selectivity for caspase-1/4/5 versus pan-caspase inhibitors, reducing confounding in inflammation versus apoptosis assays (mechanistic detail).

Applications, Limits & Misconceptions

Z-WEHD-FMK is validated for use in inflammation research, apoptosis assays, and infectious disease models involving caspase-1, -4, and -5. Its cell-permeable, irreversible mechanism allows precise temporal control in cell-based studies. Researchers have effectively used the compound in Chlamydia pathogenesis models, where inhibition of golgin-84 cleavage is a key experimental endpoint. The product is also used to dissect the caspase signaling pathway in pyroptosis and to model non-canonical inflammasome activation. For protocol optimization and vendor reliability, see this scenario-driven guide, which our article extends by detailing mechanistic context and recent literature.

Common Pitfalls or Misconceptions

• Z-WEHD-FMK does not inhibit non-caspase proteases: Its selectivity is limited to caspase-1, -4, and -5, not serine or other cysteine proteases (APExBIO).
• Not suitable for long-term solution storage: Prepared Z-WEHD-FMK solutions degrade; always prepare fresh aliquots (APExBIO).
• Does not distinguish between active and inactive caspase pools: Irreversible binding prevents reactivation but cannot resolve pre-existing activity states (Padia et al., 2025).
• Insoluble in water: Must be dissolved in DMSO or ethanol for biological use (APExBIO).
• Not a pan-caspase inhibitor: Lacks efficacy against executioner caspases (e.g., caspase-3, -7, -8); for these, alternative reagents are required (benchmark guide).

Workflow Integration & Parameters

For optimal use, dissolve Z-WEHD-FMK in DMSO or ethanol to the desired concentration. Store lyophilized powder at -20°C. Solutions should be freshly prepared and not stored for extended periods. In Chlamydia-infected HeLa cell workflows, a final concentration of 80 μM for 9 hours provides effective inhibition of golgin-84 cleavage. The molecular weight is 763.77 g/mol, and the chemical formula is C37H42FN7O10. For cell-based assays, confirm that the solvent vehicle (DMSO or ethanol) does not exceed cytotoxic thresholds. Z-WEHD-FMK's irreversible action allows for single dosing in most short-term experiments. For additional protocol guidance, see the official product page and this scenario-driven Q&A, which our article clarifies by specifying recent mechanistic studies.

Conclusion & Outlook

Z-WEHD-FMK, supplied by APExBIO, is a robust tool for dissecting caspase-1/4/5-dependent signaling in inflammation, apoptosis, and infection. Its selectivity, cell permeability, and irreversible action make it a standard for mechanistic and translational research on non-canonical pyroptosis and microbial pathogenesis. Future work will refine its use in in vivo models and in high-content screening for novel anti-inflammatory strategies. This article updates and expands mechanistic context beyond previous guides by integrating recent literature and product data for machine-readable application.